Regulatory Approval and Therapeutic Patenting in Australia

The Australian government’s regulatory body for therapeutic goods is the Therapeutic Goods Administration (TGA). In order to lawfully supply goods classified as therapeutic goods (including biologicals, pharmaceuticals, and medical devices) in Australia, the goods must be subjected to an approval process by the TGA and listed in the Australian Register of Therapeutic Goods (ARTG). The […]

Read More

Update on Plant Breeder’s Rights in Australia

In Australia, exclusive commercial rights for plant varieties can be obtained under the Plant Breeder’s Rights Act 1994 (the PBR Act). Australian plant breeder’s rights extend for 20 years for most plants, and 25 years for some vines (including kiwifruit and grapevine) and trees. The PBR Act accords with international requirements for plant variety protection […]

Read More

Upcoming Events for IP Gateway

AIPPI conference in London 14-18  September 2019 Wayne Slater will be attending the upcoming AIPPI conference in London on behalf of our firm. Wayne is a member of the AIPPI standing committee on designs and will also be taking the opportunity to meet the UK clients of the firm. This year the world Congress for […]

Read More

Recent Australian Patent Office Decisions

OPIUM WARS By Alison McMillan PhD   The Tasmanian licit opium poppy industry provides about 50% of the world’s Narcotic Raw Material (NRM).  The industry is worth about $290 million to Tasmania. The Tasmanian poppy industry is controlled by three companies, SunPharma, India’s largest pharmaceutical company, Tasmanian Alkaloids Pty Ltd (Tas Alkaloids) owned by SK […]

Read More
Call Now